| |
wt/wt
|
C282Y/wt
|
C282Y/C282Y
|
C282Y/H63D
|
H63D/wt
|
H63D/H63D
|
|---|
|
Controls (n = 34)
|
26
|
4
|
–
|
–
|
4
|
–
|
|
NAFLD with normal iron stores (n = 22)a
|
13
|
1
|
–
|
–
|
6*
|
1
|
|
NAFLD with DIOS (n = 16)
|
12
|
2
|
–
|
–
|
2
|
–
|
|
CLD (n = 8)b
|
4
|
–
|
–
|
–
|
2
|
–
|
|
CLD-IO (n = 21)
|
14
|
4
|
–
|
–
|
1
|
2
|
|
Compound heterozygous HH (n = 5)
|
–
|
–
|
–
|
5
|
–
|
–
|
|
Homozygous HH (n = 12)
|
–
|
–
|
12
|
–
|
–
|
–
|
- CLD chronic liver disease, IO iron overload, HH hereditary hemochromatosis, NAFLD non-alcoholic fatty liver disease, DIOS dysmetabolic iron overload
- *p < 0.05 in patients with NAFLD vs. controls
- aone missing value
- btwo missing values
